Views & Analysis Pharma 2022: big pharma will remain a constant Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
News Oral Wegovy bolsters Novo in Q3 Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
